Faulty reasoning signals

• Biased Writer Voice - 39.5%
• Negativity Bias - 37.8%
• Hasty Generalization - 25.3%

Article text

What Is Psychopharmacology?

Take our Do I Need Therapy?

Find a therapist near me

Convenience has outpaced comprehensive care in online GLP-1 prescriptions.

In a recent study, 49 online GLP-1 sellers prescribed in as few as five minutes.

9 of 45 prescribing sites approved despite photos that didn't meet their own requirements.

Shame, not lack of information, is often what keeps patients silent about side effects.

Researchers at Yale recently built one specific, detailed patient and tried to get that patient a GLP-1 prescription from 49 different online sellers.

The simulated patient built for the study was a 27-year-old man, Asian Indian, 5 foot 9 and 237 pounds, with a BMI of 35. His chart listed hypertension, high cholesterol, and a sleep apnea diagnosis. He smoked about a cigarette a day, drank soda three or four times a week, ate fast food once or twice, slept six hours a night, and had tried one weight loss program before that hadn't worked. He wanted to lose 40 pounds, down to 197, to improve his health, improve his appearance, and feel more confident. His blood pressure and cholesterol were both elevated, and his blood sugar sat right at the edge of a prediabetes diagnosis.

By clinical standards, this was someone a doctor would reasonably prescribe a GLP-1 to in person. A legitimate case passed through 49 different websites, and almost none of them stopped to look closely at it. The researchers followed each site's process through to a prescription.

The results, published this month in JAMA, show how little stood in the way. 45 of the 49 sites prescribed. The median time from questionnaire to approval was a day or less, and two sites approved in five minutes. 34 shipped the medication, and three quarters of those charged the card and mailed the box without asking the patient to confirm anything first. Nine sites prescribed even after receiving only an upper-body photo, despite their own intake requiring a full-body photo or a photo standing on a scale, the exact check meant to catch a mismatch between what someone reports and what's true.

Key Steps in the Online Prescription Process

Nearly every site asked for height, weight, and a list of medical conditions. Fewer than half asked about diet or physical activity. Just over half asked about a history of eating disorders. About a third asked for something as basic as a blood pressure or glucose reading, a number a patient could type into a box with nobody checking it against anything real. Only two of the 49 sites asked for actual blood work before going further, and since that would have meant producing real lab results, those two attempts stopped right there.

None of this happened in person. The entire process ran online, questionnaire to approval to shipment, with no in-person visit at any point. A clinician in the room might catch a pause before an answer, or a detail that doesn't quite line up with what's on the intake form. A questionnaire doesn't hold space for that. It asks what it's programmed to ask, and whatever falls outside those questions doesn't get seen at all. Most of these sites had replaced the appointment with a form, and the form was built to be passed.

Almost none of this runs through insurance. These are self-pay transactions, and self-pay removes another layer that would normally push toward honesty. An insurer asking for documented medical necessity wants records that hold up under review. A business selling directly to a customer doesn't need that. It just needs a customer, so a person filling out the form can shape their answers the same way they'd shape a resume or a dating profile, and the only party checking any of it has a financial interest in approving the sale.

The GLP-1 Side Effects Nobody Reports

GLP-1s carry real risks: persistent nausea, vomiting, and stomach pain; loss of muscle along with fat when the weight comes off this fast, plus hair thinning that often follows; and, in rare cases, a form of vision loss serious enough to need immediate care. It's hard to think of another medication with a risk profile like that where patients tolerate this much and report so little. If a blood pressure medication caused any of it, many people would call the office the same day. Here, the same symptoms get absorbed and carried, unspoken, refill after refill.

Part of this is structural. The study found that eight percent of patients had no opportunity to ask a clinician anything at all, and for many more the only contact was an asynchronous message box. But structure doesn't fully explain it. In other areas of medicine where stigma attaches to the prescription itself, patients have been shown to hide their true experience from the people treating them. A 2023 review of cancer patients on opioids found that many under-reported pain and side effects, worried that being honest would be read as a sign of addiction and put their access to treatment at risk (Harsanyi et al., 2023). The medication is different here, but the calculation is the same: telling the truth might cost you the thing you went through so much to get. With opioids, the shame sits on the drug. With GLP-1s, it sits on the goal itself. For thinness, women will pay enormous prices that have nothing to do with money, and staying silent about a side effect is one of the cheaper ones.

Why Patients May Hide Symptoms

There's a psychological concept called self-silencing, first described by the psychologist Dana Jack in her work with women and depression . It refers to the habit of suppressing your own needs and reactions to preserve a relationship or an outcome you don't want to jeopardize (Jack, 1991). Jack was writing about marriages and families, not medication, but it starts showing up here as early as the questionnaire itself. A woman filling it out knows which answers keep the process moving and which ones might get her flagged, so a history of disordered eating gets softened, a stressful stretch of life goes unmentioned, and the weight numbers get framed however keeps the approval on track. The same instinct carries forward once the medication arrives. She might not volunteer the muscle loss, the fatigue, the moment her vision blurred for a few seconds last week. Naming any of it, on the intake form or after, risks the thing underneath it: the fear that someone, somewhere, will decide she shouldn't have this.

What Was thre Role of Oversight in GLP-1 Prescriptions?

Access to these medications has changed real lives, including some of my own clients', which is exactly why oversight was never about gatekeeping for its own sake. It existed to create a moment, however brief, where someone with training looks at you, asks a real question, and expects an honest answer before the stakes get higher.

Psychopharmacology Essential Reads

When a Medication Side Effect Mimics Mental Illness

World War II and the Genesis of Psychopharmacology

Right now, that moment is optional, and most sites have built a system where skipping it is the default. The study's authors put it plainly: convenience has outpaced care.

The wish to be thin isn't new, and it didn't need an online pharmacy to exist. What's changed is how little now stands between that wish and getting it met, a market that's learned to sell it almost instantly, with just a credit card in the way. When a desire this old runs into an option this fast, it's not hard to understand why so many people reach for it.

Chetty AK, Chen AS, Ross JS, Ramachandran R. Online Prescribing of GLP-1 Receptor Agonists. JAMA. Published online July 06, 2026. https://doi.org/10.1001/jama.2026.9131

Harsanyi, H., Cuthbert, C., & Schulte, F. (2023). The stigma surrounding opioid use as a barrier to cancer-pain management: an overview of experiences with fear, shame, and poorly controlled pain in the context of advanced cancer. Current Oncology, 30(6), 5835-5848. https://doi.org/10.3390/curroncol30060437

Jack, D. C. (1991). Silencing the self: Women and depression. Harvard University Press.

Yael Hallak is a NY Licensed Mental Health Counselor, researcher at The New School’s Gender & Health Lab, and journalist at Haaretz writing about women, health, and the psychology of self-control.

More from Yael Hallak

More from Psychology Today